» Articles » PMID: 18535808

Effects of Irradiation on the [Methyl-3H]choline Uptake in the Human Prostate Cancer Cell Lines LNCaP and PC3

Overview
Specialties Oncology
Radiology
Date 2008 Jun 7
PMID 18535808
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Choline positron emission tomography (PET) can help to optimize radiation treatment strategy of prostate cancer. Therefore, the aim of this study was to elucidate the effects of ionizing radiation on the choline uptake in an androgen-dependent (LNCaP) and an androgen-independent (PC3) prostate cancer cell line.

Material And Methods: Uptake of [methyl-(3)H]choline chloride was investigated between 4 and 96 h after irradiation with 6 Gy. Dose dependence of choline uptake was examined following irradiation with 2-12 Gy, and cell survival was analyzed via the clonogenic assay. Michaelis-Menten kinetics was determined 24 h (PC3) and 48 h (LNCaP) after irradiation with 6 Gy.

Results: PC3 cells showed a significant transitory increase of [methyl-(3)H]choline uptake with a maximum at 24 h after irradiation. In LNCaP cells irradiation induced a significant decrease with a minimum at 48 h. Changes in choline uptake in both cell lines were almost dose-independent up to 12 Gy. Following irradiation with 6 Gy, transport capacity (v(max)) increased and Michaelis-Menten constant (K(M)) decreased in PC3 cells, while in LNCaP cells the two parameters behaved vice versa.

Conclusion: Changes in choline uptake following irradiation might be due to metabolic changes associated with initiation of processes that finally cause cell death. Thus, changes in tumor choline uptake monitored by PET after radiotherapy might not exclusively reflect therapeutic success but also altered tracer uptake as a consequence of irradiation.

Citing Articles

Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring.

Challapalli A, Aboagye E Front Oncol. 2016; 6:44.

PMID: 26973812 PMC: 4770188. DOI: 10.3389/fonc.2016.00044.


Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model.

Schwarzenbock S, Gertz J, Souvatzoglou M, Kurth J, Sachs D, Nawroth R Mol Imaging Biol. 2014; 17(2):248-56.

PMID: 25163420 DOI: 10.1007/s11307-014-0782-8.


18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.

Brogsitter C, Zophel K, Kotzerke J Eur J Nucl Med Mol Imaging. 2013; 40 Suppl 1:S18-27.

PMID: 23579863 DOI: 10.1007/s00259-013-2358-2.


[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model.

Krause B, Souvatzoglou M, Herrmann K, Weber A, Schuster T, Buck A Eur J Nucl Med Mol Imaging. 2010; 37(10):1861-8.

PMID: 20512572 DOI: 10.1007/s00259-010-1493-2.


Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use.

Cambria R, Jereczek-Fossa B, Cattani F, Garibaldi C, Zerini D, Fodor C Strahlenther Onkol. 2009; 185(6):384-9.

PMID: 19506822 DOI: 10.1007/s00066-009-1933-8.